Biopharma | June 05, 2026
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
Subscribe To Our Newsletter & Stay Updated
